PROPHYLAXIS OF THROMBOEMBOLIC EVENTS IN CANCER PATIENTS

摘要

The present invention generally relates a method of prophylaxis of thrombotic and thromboembolic events in a cancer patient in need thereof comprising administering to said patient a therapeutically effective amount of a factor Xa inhibitor, especially apixaban or a polymorph or pharmaceutically acceptable solvate form thereof. The factor Xa inhibitor may be used in combination with therapeutic agents.